216
Views
2
CrossRef citations to date
0
Altmetric
Commentary

Itraconazole-induced thrombocytopenia

Pages 305-306 | Received 02 Oct 2016, Accepted 03 Nov 2016, Published online: 21 Dec 2016

References

  • Gupta AK, Lane D, Paquet M. Systematic review of systemic treatments for tinea versicolor and evidence-based dosing regimen recommendations. J Cutan Med Surg 2014;18:79–90.
  • Horst HA, Parwaresch R, Löffler H. Thrombocytopenia and leukopenia associated with itraconazole. Ann Intern Med 1996;125:156–157.
  • Iwamoto T, Ishibashi M, Fujieda A, et al. Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib. Pharmacotherapy 2010;30:661–665.
  • Liebman HA. Thrombocytopenia in cancer patients. Thromb Res 2014;133(Suppl 2):S63–S69.
  • Arnold DM, Nazi I, Warkentin TE, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev 2013;27:137–145.
  • Kaushansky A, Kaushansky K. Systems biology of megakaryocytes. Adv Exp Med Biol 2014;844:59–84.
  • Hau CS, Kanda N, Makimura K, Watanabe S. Antimycotics suppress the Malassezia extract-induced production of CXC chemokine ligand 10 in human keratinocytes. J Dermatol 2014;41:124–134.
  • Morris MI. Posaconazole: a new oral antifungal agent with an expanded spectrum of activity. Am J Health Syst Pharm 2009;66:225–236.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.